Navigating Cybersecurity Compliance: A Lifecycle Approach for Medical Device Manufacturers

As global regulators tighten their cybersecurity expectations, medical device manufacturers (MDMs) face unprecedented scrutiny across the entire product lifecycle.

This joint whitepaper from Medcrypt and the Johner Institute provides a comprehensive roadmap for achieving cybersecurity compliance across multiple jurisdictions, including the U.S. FDA, EU MDR/IVDR, and international standards such as IEC 81001-5-1.

The paper clarifies how manufacturers can integrate security practices into their quality management systems (QMS) and software lifecycle processes, and provides side-by-side mappings of global regulatory expectations. It also includes real-world examples of FDA and EU market approval rejections caused by insufficient cybersecurity documentation and testing, offering lessons learned and practical remediation strategies.

Cybersecurity is now a decisive factor in regulatory approval for medical devices. Both the FDA and European Notified Bodies have begun rejecting submissions solely for cybersecurity shortcomings — including missing SBOMs, inadequate threat modeling, or lack of postmarket surveillance planning.

This whitepaper helps manufacturers navigate these heightened expectations by:

• Global regulatory bodies are aligning on lifecycle-based cybersecurity frameworks, increasing the need for cross-functional coordination.
• The most common causes of market approval rejection include missing documentation, lack of traceability, and unqualified personnel.
• IEC 81001-5-1 has become the unifying backbone for both U.S. and EU cybersecurity expectations.
• Integrating cybersecurity into QMS and design controls early reduces rework, delays, and rejection risk.
• Medcrypt and Johner Institute provide frameworks and tooling to help manufacturers operationalize compliance efficiently.